These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29305870)

  • 1. Ophthalmic Econazole Hydrogels for the Treatment of Fungal Keratitis.
    Díaz-Tomé V; Luaces-Rodríguez A; Silva-Rodríguez J; Blanco-Dorado S; García-Quintanilla L; Llovo-Taboada J; Blanco-Méndez J; García-Otero X; Varela-Fernández R; Herranz M; Gil-Martínez M; Lamas MJ; González-Barcia M; Otero-Espinar FJ; Fernández-Ferreiro A
    J Pharm Sci; 2018 May; 107(5):1342-1351. PubMed ID: 29305870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
    Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
    Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging.
    Luaces-Rodríguez A; Díaz-Tomé V; González-Barcia M; Silva-Rodríguez J; Herranz M; Gil-Martínez M; Rodríguez-Ares MT; García-Mazás C; Blanco-Mendez J; Lamas MJ; Otero-Espinar FJ; Fernández-Ferreiro A
    Int J Pharm; 2017 Aug; 528(1-2):714-722. PubMed ID: 28634142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole-Cyclodextrin Supramolecular Ternary Complex-Loaded Ocular Films for Management of Fungal Keratitis.
    Suvarna P; Chaudhari P; Birangal S; Mallela LS; Roy S; Koteshwara A; Aranjani JM; Lewis SA
    Mol Pharm; 2022 Jan; 19(1):258-273. PubMed ID: 34928610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis.
    Díaz-Tomé V; García-Otero X; Varela-Fernández R; Martín-Pastor M; Conde-Penedo A; Aguiar P; González-Barcia M; Fernández-Ferreiro A; Otero-Espinar FJ
    Int J Pharm; 2021 Mar; 597():120318. PubMed ID: 33540021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug.
    Sayed S; Elsayed I; Ismail MM
    Int J Pharm; 2018 Oct; 549(1-2):249-260. PubMed ID: 30077759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Composite System Based upon Hydroxypropyl Cyclodextrins and Soft Hydrogel Contact Lenses for the Delivery of Therapeutic Doses of Econazole to the Cornea, In Vitro.
    Wong A; Fallon M; Celiksoy V; Ferla S; Varricchio C; Whitaker D; Quantock AJ; Heard CM
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular supersaturated self-nanoemulsifying drug delivery systems (S-SNEDDS) to enhance econazole nitrate bioavailability.
    Elkasabgy NA
    Int J Pharm; 2014 Jan; 460(1-2):33-44. PubMed ID: 24184217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan.
    Fernández-Ferreiro A; Silva-Rodríguez J; Otero-Espinar FJ; González-Barcia M; Lamas MJ; Ruibal A; Luaces-Rodríguez A; Vieites-Prado A; Lema I; Herranz M; Gómez-Lado N; Blanco-Mendez J; Gil-Martínez M; Pardo M; Moscoso A; Cortes J; Sánchez-Martínez M; Pardo-Montero J; Aguiar P
    Eur J Pharm Biopharm; 2017 May; 114():317-323. PubMed ID: 28189624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan.
    Fernández-Ferreiro A; González Barcia M; Gil-Martínez M; Vieites-Prado A; Lema I; Argibay B; Blanco Méndez J; Lamas MJ; Otero-Espinar FJ
    Eur J Pharm Biopharm; 2015 Aug; 94():342-51. PubMed ID: 26079831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity--drug supersaturation, toxicity on TR146 cells and release from a delivery system.
    Jacobsen J; Bjerregaard S; Pedersen M
    Eur J Pharm Biopharm; 1999 Nov; 48(3):217-24. PubMed ID: 10612032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoadhesive self-emulsifying delivery systems for ocular administration of econazole.
    Elbahwy IA; Lupo N; Ibrahim HM; Ismael HR; Kasem AA; Caliskan C; Matuszczak B; Bernkop-Schnürch A
    Int J Pharm; 2018 Apr; 541(1-2):72-80. PubMed ID: 29458206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of the Ocular Bioavailability of Econazole Nitrate upon Complexation with Cyclodextrins.
    Abd El-Gawad AEH; Soliman OA; El-Dahan MS; Al-Zuhairy SAS
    AAPS PharmSciTech; 2017 Jul; 18(5):1795-1809. PubMed ID: 27830515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracorneal melatonin delivery using 2-hydroxypropyl-β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2.
    Ahn JH; Kim HD; Abuzar SM; Lee JY; Jin SE; Kim EK; Hwang SJ
    Int J Pharm; 2017 Aug; 529(1-2):608-616. PubMed ID: 28694094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal activity of econazole nitrate/cyclodextrin complex: Effect of pH and formation of complex aggregates.
    Jansook P; Prajapati M; Pruksakorn P; Loftsson T
    Int J Pharm; 2020 Jan; 574():118896. PubMed ID: 31765779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking.
    Conde Penedo A; Díaz Tomé V; Fernández Ferreiro A; González Barcia M; Otero Espinar FJ
    Eur J Pharm Biopharm; 2021 May; 162():12-22. PubMed ID: 33667681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis.
    Prajna NV; John RK; Nirmalan PK; Lalitha P; Srinivasan M
    Br J Ophthalmol; 2003 Oct; 87(10):1235-7. PubMed ID: 14507756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of itraconazole ocular delivery system using β-cyclodextrin complexation incorporated into dissolving microneedles for potential improvement treatment of fungal keratitis.
    Putri RA; Enggi CK; Sulistiawati S; Burhanuddin H; Iskandar IW; Saputra RR; Rahman L; Sartini S; Rifai Y; Aswad M; Permana AD
    J Biomater Sci Polym Ed; 2024 Oct; 35(15):2315-2342. PubMed ID: 39083398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
    Fu T; Yi J; Lv S; Zhang B
    J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.